A Randomized Comparative Clinical Study On The Efficacy Of Mehmudgar Ras Vati With And Without Virechan Karma In The Management Of Timir W.S.R.To Diabetic Macular Edema (DME)

Dr Ankur Tripathi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients willing to participate in this trial through written informed consent.
•Patients who are 40-70 years of age from either sex.
•Patients having specific symptoms of prameh janya timira /D.M.E.
•Diagnosed cases of diabetics mellitus type2 with NPDR cases with macular edema.
•Good visual acuity, minimum 6/60 or better

•Patients not willing for the present treatment.
•Patients having history of glaucoma and on anti glaucoma treatment.
•Patients below age of 40 and above 70.
•Patients with moderate to severe cataractous changes.
•Patients having proliferative and advanced diabetic retinopathy changes.
•Patients with any other complications of Diabetes like nephropathy and neuropathy.
•Visual acuity less than 6/60.
•Hypertensive/pregnant/diabetic mellitus type 1

发起方

Dr Ankur Tripathi